Inventor · disambiguated record
Anthony R. Haight
Also filed as: HAIGHT ANTHONY R · HAIGHT ANTHONY RALPH · HAIGHT Anthony · MORTON HOWARD E
41 granted patents·13 pending applications·409 citations·filing 1992–2024
98Inventor score
Top patents by PatentIndex Score
54 records- 0195US6437106B1Process for preparing 6-o-substituted erythromycin derivativesABBOTT LAB·Filed 2000·Granted Aug 20, 2002·161 cites·30 claims
- 0292US8841487B2Phosphine ligands for catalytic reactionsSHEKHAR SHASHANK·Filed 2011·Granted Sep 23, 2014·8 cites·29 claims
- 0391US9381508B2Phosphine ligands for catalytic reactionsABBVIE INC·Filed 2015·Granted Jul 5, 2016·3 cites·22 claims
- 0491US6150530ARetroviral protease inhibiting compoundsABBOTT LAB·Filed 1998·Granted Nov 21, 2000·35 cites·24 claims
- 0591US5491253AProcess for the preparation of a substituted 2,5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1994·Granted Feb 13, 1996·25 cites·4 claims
- 0690US9200021B2Phosphine ligands for catalytic reactionsABBVIE INC·Filed 2015·Granted Dec 1, 2015·3 cites·38 claims
- 0789US8168784B2Processes to make apoptosis promotersFRANCZYK II THADDEUS STEPHAN·Filed 2009·Granted May 1, 2012·31 cites·10 claims
- 0888US7576216B2Preparation of pyridonecarboxylic acid antibacterialsABBOTT LAB·Filed 2005·Granted Aug 18, 2009·4 cites·2 claims
- 0988US5580984ARetroviral protease inhibiting compoundsABBOTT LAB·Filed 1995·Granted Dec 3, 1996·16 cites·5 claims
- 1087US8975443B2Phosphine ligands for catalytic reactionsSHEKHAR SHASHANK·Filed 2012·Granted Mar 10, 2015·4 cites·30 claims
- 1187US6046207ABenzopyranopyrrole and benzopyranopyridine α-1 adrenergic compoundsFiled 1997·Granted Apr 4, 2000·37 cites·4 claims
- 1284US2025177374A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2024·Application pending·0 cites
- 1382US9266913B2Phosphine ligands for catalytic reactionsABBVIE INC·Filed 2014·Granted Feb 23, 2016·3 cites·16 claims
- 1482US6017928ARetroviral protease inhibiting compoundsABBOTT LAB·Filed 1997·Granted Jan 25, 2000·15 cites·4 claims
- 1582US5616776AProcess for the preparation of a substituted 2.5-diamono-3-hydroxy-hexaneABBOTT LAB·Filed 1995·Granted Apr 1, 1997·14 cites·3 claims
- 1679US9434698B2Process for preparing antiviral compoundsABBVIE INC·Filed 2014·Granted Sep 6, 2016·1 cites·30 claims
- 1779US8299254B2Preparation of pyridonecarboxylic acid antibacterialsHAIGHT Anthony·Filed 2009·Granted Oct 30, 2012·2 cites·19 claims
- 1878US8895737B2Process for preparing antiviral compoundsSHEKHAR SHASHANK·Filed 2011·Granted Nov 25, 2014·5 cites·23 claims
- 1977US5654466AProcess for the preparation of a disubstituted 2,5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1996·Granted Aug 5, 1997·9 cites·4 claims
- 2077US2024058450A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2022·Application pending·0 cites
- 2173US2020246460A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 2272US5284954AProcess for the preparation of tetrazolesABBOTT LAB·Filed 1992·Granted Feb 8, 1994·16 cites·13 claims
- 2371US2025122269A1Selective reduction of antibodiesABBVIE INC·Filed 2024·Application pending·0 cites
- 2469US8377913B2Vitamin D receptor activators and methods of makingABBVIE INC·Filed 2008·Granted Feb 19, 2013·1 cites·5 claims
- 2569US8232411B2Methods for making central nervous system agents that are TRPV1 antagonistsLUKIN KIRILL A·Filed 2009·Granted Jul 31, 2012·2 cites·9 claims
- 2669US2015094475A1Preparation of Pyridonecarboxylic Acid AntibacterialsABBVIE INC·Filed 2014·Application pending·0 cites
- 2768US8927723B2Preparation of pyridonecarboxylic acid antibacterialsABBVIE INC·Filed 2014·Granted Jan 6, 2015·0 cites·1 claims
- 2865US9732045B2Process for preparing antiviral compoundsABBVIE INC·Filed 2016·Granted Aug 15, 2017·0 cites·3 claims
- 2965US8648196B2Preparation of pyridonecarboxylic acid antibacterialsABBVIE INC·Filed 2012·Granted Feb 11, 2014·0 cites·20 claims
- 3064US2020239553A1BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 3163US9669399B2Phosphine ligands for catalytic reactionsABBVIE INC·Filed 2016·Granted Jun 6, 2017·0 cites·20 claims
- 3262US2019142941A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 3361US9255074B2Process for preparing antiviral compoundsSHEKHAR SHASHANK·Filed 2012·Granted Feb 9, 2016·0 cites·56 claims
- 3458US2021017222A1Selective reduction of antibodiesABBVIE INC·Filed 2019·Application pending·0 cites
- 3557US5508409AProcess for the preparation of a substituted 2.5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1995·Granted Apr 16, 1996·3 cites·2 claims
- 3653US2016339117A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2015·Application pending·0 cites
- 3752US5565604AProcess for the preparation of a substituted 2,5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1995·Granted Oct 15, 1996·2 cites·1 claims
- 3851US6667404B2Retroviral protease inhibiting compoundsABBOTT LAB·Filed 2003·Granted Dec 23, 2003·0 cites·23 claims
- 3947US8399468B2Octahydro-pyrrolo[3,4-B]pyrrole derivativesCOWART MARLON D·Filed 2010·Granted Mar 19, 2013·0 cites·14 claims
- 4044US5672706AProcess for the preparation of a substituted 2,5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1996·Granted Sep 30, 1997·4 cites·15 claims
- 4142US2016158377A1BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the SameACKLER SCOTT L·Filed 2015·Application pending·0 cites
- 4241US5543551AProcess for the preparation of a substituted 2.5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1995·Granted Aug 6, 1996·2 cites·2 claims
- 4339US5932766AProcess for the preparation of substituted keto-enaminesABBOTT LAB·Filed 1997·Granted Aug 3, 1999·2 cites·22 claims
- 4437US5543549AProcess for the preparation of a substituted 2,5-Diamino-3-HydroxyhexaneABBOTT LAB·Filed 1995·Granted Aug 6, 1996·0 cites·2 claims
- 4537US2010297194A1Formulation for oral administration of apoptosis promoterCATRON NATHANIEL·Filed 2010·Application pending·0 cites
- 4636US7071314B2Arylation method for the functionalization of O-allyl erythromycin derivativesABBOTT LAB·Filed 2002·Granted Jul 4, 2006·0 cites·12 claims
- 4736US6124474ASynthesis of chiral 2-azetidinemethanol compoundsABBOTT LAB·Filed 1999·Granted Sep 26, 2000·1 cites·12 claims
- 4836US5625092AProcess for the preparation of a substituted 2.5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1995·Granted Apr 29, 1997·0 cites·2 claims
- 4936US5541328AProcess for the preparation of a substituted 2,5-diamino-3-hydroxyhexaneABBOTT LAB·Filed 1995·Granted Jul 30, 1996·0 cites·5 claims
- 5036US2011190540A1Methods for Preparing S1P Receptor Agonists and AntagonistsABBOTT LAB·Filed 2010·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anthony R. Haight files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →